Picture this: Among the cirque du swag of the BIO 2006 exhibit hall in Chicago, a cheerful young scientist pads up to the booth of a certain magazine of the life sciences. On scanning her nametag, one of my colleagues notices an interesting affiliation: Philip Morris. Intrigued, my colleague asks the senior research scientist about her work, which she says involves "harm reduction."












